Anteo Diagnostics Limited
(ASX:ADO) CEO Dr Geoff Cumming presents at ASX Spotlight Series in New York.
The lifesciences company’s presentation includes a company profile, financial snapshot, core competencies and IP strategy.
Dr Cumming also discusses Anteo’s products, diagnostic industry drivers, blue sky opportunities and planned milestones for 2015.
Introducing the company Dr Cumming says, “I would like to give you a brief overview of Anteo Diagnostics, what we do, the composition of the company, our technology, some of the areas we are involved in and why we believe that we are a rapidly growing company that will accelerate that growth into future, and why it might represent a worthwhile investment opportunity for you.
We work in the biotechnology space. Australia does have a vibrant healthcare, lifesciences biotechnology space.”
